kabutan

CellSeed Inc.(7776) Summary

7776
TSE Growth
CellSeed Inc.
315
JPY
+13
(+4.30%)
Feb 13, 3:30 pm JST
2.05
USD
Feb 13, 1:30 am EST
Result
PTS
outside of trading hours
305
Feb 14, 12:25 am JST
Summary Chart Historical News Financial Result
PER
PBR
8.91
Yield
ー%
Margin Trading Ratio
47,560.00
Stock Price
Feb 13, 2026
Opening Feb 13, 9:00 am
300 JPY 1.96 USD
Previous Close Feb 12
302 JPY 1.96 USD
High Feb 13, 3:11 pm
332 JPY 2.16 USD
Low Feb 13, 2:53 pm
291 JPY 1.89 USD
Volume
1,727,500
Trading Value
0.54B JPY 3.53M USD
VWAP
313.49 JPY 2.05 USD
Minimum Trading Value
31,500 JPY 205 USD
Market Cap
0.01T JPY 0.07B USD
Number of Trades
1,867
Liquidity & Number of Trades
As of Feb 13, 2026
Liquidity
High
1-Year Average
1,170
1-Year High Mar 27, 2025
29,466
Margin Trading
Date Short Interest Long Margin Positions Ratio
Feb 6, 2026 0 3,559,600
Jan 30, 2026 0 3,722,000
Jan 23, 2026 0 3,759,200
Jan 16, 2026 0 3,886,300
Jan 9, 2026 0 3,419,600
Company Profile
CellSeed Inc. is a biotech venture originating from Tokyo Women's Medical University, primarily focused on cell sheet regenerative medicine and regenerative medicine support.
Sector
Precision Instruments
CellSeed Inc. is based on cell sheet engineering technology and aims to promote the global adoption of cell sheet regenerative medicine. The company operates in two main areas: regenerative medicine support and cell sheet regenerative medicine. In the regenerative medicine support business, CellSeed Inc. conducts research, development, manufacturing, and sales of temperature-responsive cell culture equipment and related products. The cell sheet regenerative medicine business involves the research, development, manufacturing, and sales of cell sheet regenerative medicine products and their applications.